Hosted on MSN5d
Abbott's Freestyle Libre CGMs Cleared for Use During Imaging Tests
But now, Abbott’s FreeStyle Libre 2 and 3 have received the first and only FDA clearance that allows patients to keep their ...
Abbott3d
FreeStyle Libre: How a Diabetes Breakthrough was Born
FreeStyle Libre CGMs, a breakthrough in diabetes care, actually started as a failed product — but key changes made it the ...
Medscape14d
Newer Abbott Libre CGM Sensor Use Now Okay During Imaging
The US Food and Drug Administration has okayed removal of the contraindication for use during CT and MRI under certain ...
PharmiWeb18d
Abbott's FreeStyle Libre® 2 and 3: First Continuous Glucose Monitoring Systems Approved for Use During Medical Imaging
Abbott today announced that its FreeStyle Libre 2 and 3 systems can now be worn during common imaging procedures, such as X-rays, CT scans and MRIs*. The U.S. Food and Drug Administration (FDA) ...
HME News6h
Abbott opens new facility for sensors, CGMs
Abbott on Nov. 18 held a ceremony to celebrate the official opening of a state-of-the-art manufacturing facility in Kilkenny, ...
MassDevice9h
Abbott opens new FreeStyle Libre manufacturing plant in Ireland
Abbott (NYSE:ABT) today announced a significant milestone abroad with the opening of a new manufacturing facility in Ireland.
Business Wire21d
Tidepool Will Integrate With Abbott’s FreeStyle Libre Portfolio for Seamless Cloud-to-Cloud Data
We are excited to work with Abbott to empower healthcare providers and people ... Tidepool+ will be able to initiate the ...
New Canadian Report Shows Positivity Instead of Criticism is Key in Diabetes Management
Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.